Summarily, inhibiting NLRP3 inflammasome activation by CY-09 helps to restore cerebral glucose metabolism, improve memory and learning ability, and reduce fatty acid synthesis and lipid peroxidation in the 3×Tg-AD mice. Here, NLRP3 is linked to Alzheimer disease.